The International Core (1C) has been a major element of the UAB CFAR since 1997. With the change in CFAR and 1C leadership in this last project period, the 1C has sharply focused on Zambia and the remarkable achievements occurring there, principally through a direct partnership with the Center for Infectious Diseases Research in Zambia (CIDRZ). The CFAR helped establish CIDRZ in the late 1990s with a mission to provide infrastructure support for HIV related research and treatment programs in Zambia. Over the last funding period, the CFAR has enabled CIDRZ to create laboratory capacity in high-through put clinical laboratory testing, high quality flow cytometry for accurate CD4 determinations, viral load testing, TB culture and rapid diagnostic techniques, and HIV resistance capabilities. The most important role CFAR has played is in creating the clinical care protocols and infrastructure to support the rollout of the PEPFAR program via CIDRZ and the Zambian Ministry of Health. Using this remarkable system, the PEPFAR program in Lusaka now operates in 46 community clinics and has evaluated over 165,000 HIV infected patients, placing over 100,000 of them on ARV treatment. The CIDRZ team, since 1999, has evaluated over 500,000 pregnant women for prevention of mother-to-child transmission and prevented tens of thousands of infants from becoming HIV infected. The CFAR helped create the proper infrastructure to support DAIDS-sponsored Network clinical trials and a specimen repository that is used to support the clinical-translational studies in Lusaka, helping to establish bidirectional research and training opportunities between Zambian and UAB investigators.
The Specific Aims of the 1C for this next project period are: 1) To develop further the CFAR/CIDRZ specimen repository in order to provide patient samples to investigators with high-quality research ideas, with a focus on projects most relevant to Zambia; 2) To develop further the CFAR/CIDRZ data repository in order to provide analysis datasets and analytic support to investigators with high-quality research ideas, paying special attention to junior investigators and Zambian investigators; 3) To provide bidirectional training in clinical and basic science research for Birmingham-based CFAR Members and Zambian Investigators; 4) To provide leadership and strategic planning for CIDRZ and other CFAR collaborators in Zambia through support of the CIDRZ Scientific Advisory Committee. The measures for success for the 1C will be the number of new programs initiated and supported, numbers of new grant proposals submitted including Developmental Grant proposals, numbers of publications from ongoing projects, the number of new Zambian investigators trained by the Core and their productivity, and the contributions by other UAB groups or centers to the overall 1C effort.

Public Health Relevance

HIV is a global pandemic that affects millions of people world-wide. The hardest hit area of the world is Sub-Saharan Africa. Our effort to combat AIDS in Zambia places us in the heart of the epidemic, where coordinated research, treatment, and prevention efforts are desperately needed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-22
Application #
8103118
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
22
Fiscal Year
2010
Total Cost
$523,803
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Frugé, Andrew D; Van der Pol, William; Rogers, Laura Q et al. (2018) Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. J Acad Nutr Diet :
Dionne-Odom, Jodie; Westfall, Andrew O; Van Der Pol, Barbara et al. (2018) Sexually Transmitted Infection Prevalence in Women With HIV: Is There a Role for Targeted Screening? Sex Transm Dis 45:762-769
Crenshaw, Brennetta J; Gu, Linlin; Sims, Brian et al. (2018) Exosome Biogenesis and Biological Function in Response to Viral Infections. Open Virol J 12:134-148
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Sahay, Bikash; Bashant, Kathleen; Nelson, Nicole L J et al. (2018) Induction of Interleukin 10 by Borrelia burgdorferi Is Regulated by the Action of CD14-Dependent p38 Mitogen-Activated Protein Kinase and cAMP-Mediated Chromatin Remodeling. Infect Immun 86:
Trapecar, Martin; Khan, Shahzada; Cohn, Benjamin L et al. (2018) B cells are the predominant mediators of early systemic viral dissemination during rectal LCMV infection. Mucosal Immunol 11:1158-1167
Verma, Richa; Sahu, Rajnish; Dixit, Saurabh et al. (2018) The Chlamydia M278 Major Outer Membrane Peptide Encapsulated in the Poly(lactic acid)-Poly(ethylene glycol) Nanoparticulate Self-Adjuvanting Delivery System Protects Mice Against a Chlamydia muridarum Genital Tract Challenge by Stimulating Robust Systemic Front Immunol 9:2369

Showing the most recent 10 out of 955 publications